A Dark Vector Cognition product

Item 4. Controls and Procedures

3K characters. Original on sec.gov · Markdown

Item 4. Controls and Procedures

The Company maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management in a timely manner. Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial officer, we have evaluated the effectiveness of our system of disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of September 30, 2025. Based on that evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are effective at the reasonable assurance level.

Such evaluation did not identify any change in the Company’s internal control over financial reporting during the quarter ended September 30, 2025 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) Purchase of equity securities by the issuer and affiliated purchasers.

The following table reflects purchases of AMETEK, Inc. common stock by the Company during the three months ended September 30, 2025:

PeriodTotal Number of Shares Purchased (1)(2)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plan (2)Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
July 1, 2025 to July 31, 2025—$——$1,242,922,017
August 1, 2025 to August 31, 202553,824186.0553,8241,232,907,972
September 1, 2025 to September 30, 2025750,032187.31750,0321,092,421,787
Total803,856$187.22803,856

(1) Represents shares surrendered to the Company to satisfy tax withholding obligations in connection with employees’ share-based compensation awards.

(2) Effective February 7, 2025, the Company's Board of Directors approved a $1.25 billion share repurchase

authorization. This new authorization replaces the previous $1 billion share repurchase authorization approved in

May 2022. Consists of the number of shares purchased pursuant to the Company’s Board of Directors $1.25 billion authorization for the repurchase of its common stock. Such purchases may be effected from time to time in the open market or in private transactions, subject to market conditions and at management’s discretion.

Previous: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations · Next: Item 5. Other Information